Investor Create sustained value increase for investors Home>Investor Announcements and Circulars Learn More 09-12 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 09-12 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 09-12 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 09-12 2019 JOINT ANNOUNCEMENT - THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF SHANGHAI HENLIUS ON THE MAIN BOARD OF THE HONG KONG STOCK EXCHANGE - PUBLICATION OF THE PROSPECTUS ISSUED BY SHANGHAI HENLIUS BIOTECH, INC. - EXPECTED SIZE OF THE GLOBAL OFFERING AND OFFER PRICE RANGE (H SHARES) 09-12 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) Govemance Learn More 06-25 2019 Articles of Association 12-27 2018 Board Diversity Policy 12-27 2018 Terms of Reference and Implementation Rules of the Nomination Committee under the Board of Directors 12-27 2018 Terms of Reference and Implementation Rules of the Audit Committee under the Board of Directors 10-30 2012 Terms of Reference and Implementation Rules of the Strategic Committee under the Board of Directors Stock Info 600196-SH 18.7 0.120.64% 02196-HK 26.25 0.150.57% Reports Interim Report 2019 (H SHARES) 2018 Corporate Social Responsibility Report Investor Contact Contact: Li Xinlei Tel：+86-21-33987870 Fax：+86-21-33987020 Mail：ir@fosunpharma.com lixinlei@fosunpharma.com